全文获取类型
收费全文 | 18964篇 |
免费 | 1119篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 141篇 |
儿科学 | 582篇 |
妇产科学 | 375篇 |
基础医学 | 3697篇 |
口腔科学 | 208篇 |
临床医学 | 1920篇 |
内科学 | 3826篇 |
皮肤病学 | 542篇 |
神经病学 | 1588篇 |
特种医学 | 654篇 |
外科学 | 2163篇 |
综合类 | 111篇 |
一般理论 | 4篇 |
预防医学 | 1415篇 |
眼科学 | 323篇 |
药学 | 1199篇 |
中国医学 | 45篇 |
肿瘤学 | 1323篇 |
出版年
2023年 | 93篇 |
2022年 | 73篇 |
2021年 | 311篇 |
2020年 | 197篇 |
2019年 | 302篇 |
2018年 | 499篇 |
2017年 | 341篇 |
2016年 | 409篇 |
2015年 | 463篇 |
2014年 | 557篇 |
2013年 | 788篇 |
2012年 | 1320篇 |
2011年 | 1367篇 |
2010年 | 674篇 |
2009年 | 562篇 |
2008年 | 1197篇 |
2007年 | 1183篇 |
2006年 | 1166篇 |
2005年 | 1204篇 |
2004年 | 1070篇 |
2003年 | 1006篇 |
2002年 | 918篇 |
2001年 | 282篇 |
2000年 | 234篇 |
1999年 | 219篇 |
1998年 | 100篇 |
1997年 | 91篇 |
1996年 | 77篇 |
1995年 | 75篇 |
1994年 | 71篇 |
1993年 | 68篇 |
1992年 | 109篇 |
1991年 | 109篇 |
1990年 | 117篇 |
1989年 | 122篇 |
1988年 | 106篇 |
1987年 | 97篇 |
1986年 | 90篇 |
1985年 | 84篇 |
1984年 | 79篇 |
1983年 | 56篇 |
1979年 | 79篇 |
1978年 | 59篇 |
1975年 | 56篇 |
1974年 | 66篇 |
1973年 | 65篇 |
1933年 | 65篇 |
1932年 | 66篇 |
1931年 | 63篇 |
1927年 | 64篇 |
排序方式: 共有10000条查询结果,搜索用时 796 毫秒
1.
Key Jana Maletzko Antonia Kohli Aneesha Gispert Suzana Torres-Odio Sylvia Wittig Ilka Heidler Juliana Bárcena Clea López-Otín Carlos Lei Yuanjiu West A. Phillip Münch Christian Auburger Georg 《Neurogenetics》2020,21(3):187-203
neurogenetics - Human RNF213, which encodes the protein mysterin, is a known susceptibility gene for moyamoya disease (MMD), a cerebrovascular condition with occlusive lesions and compensatory... 相似文献
2.
3.
4.
5.
Marie V. Plaisime PhD MPH Marie Jipguep-Akhtar PhD Joseph J. Locascio PhD Harolyn M. E. Belcher MD MHS Rachel R. Hardeman PhD MPH Katherine Picho-Kiroga PhD Sylvia P. Perry PhD Sean M. Phelan PhD MPH Michelle van Ryn PhD LMFT MPH John F. Dovidio PhD 《Health services research》2023,58(Z2):229-237
Objective
To examine the experience of interracial anxiety among health professionals and how it may affect the quality of their interactions with patients from racially marginalized populations. We explored the influence of prior interracial exposure—specifically through childhood neighborhoods, college student bodies, and friend groups—on interracial anxiety among medical students and residents. We also examined whether levels of interracial anxiety change from medical school through residency.Data Source
Web-based longitudinal survey data from the Medical Student Cognitive Habits and Growth Evaluation Study.Study Design
We used a retrospective longitudinal design with four observations for each trainee. The study population consisted of non-Black US medical trainees surveyed in their 1st and 4th years of medical school and 2nd and 3rd years of residency. Mixed effects longitudinal models were used to assess predictors of interracial anxiety and assess changes in interracial anxiety scores over time.Principal Findings
In total, 3155 non-Black medical trainees were followed for 7 years. Seventy-eight percent grew up in predominantly White neighborhoods. Living in predominantly White neighborhoods and having less racially diverse friends were associated with higher levels of interracial anxiety among medical trainees. Trainees' interracial anxiety scores did not substantially change over time; interracial anxiety was highest in the 1st year of medical school, lowest in the 4th year, and increased slightly during residency.Conclusions
Neighborhood and friend group composition had independent effects on interracial anxiety, indicating that premedical racial socialization may affect medical trainees' preparedness to interact effectively with diverse patient populations. Additionally, the lack of substantial change in interracial anxiety throughout medical training suggests the importance of providing curricular tools and structure (e.g., instituting interracial cooperative learning activities) to foster the development of healthy interracial relationships. 相似文献6.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献7.
Frédéric Janvier Deborah Delaune Thomas Poyot Eric Valade Audrey Mérens Pierre E. Rollin Vincent Foissaud 《Emerging infectious diseases》2016,22(2):292-294
We evaluated RNA stability of Ebola virus in EDTA blood and urine samples collected from infected patients and stored in West Africa’s environmental conditions. In blood, RNA was stable for at least 18 days when initial cycle threshold values were <30, but in urine, RNA degradation occurred more quickly. 相似文献
8.
9.
10.